Case Study Presented at the 2012 Fall Symposium on Advanced Wound Care
EMERYVILLE, Calif., Sept. 13, 2012 (GLOBE NEWSWIRE) -- NovaBay ® Pharmaceuticals, Inc. (NYSE-MKT:NBY), a clinical-stage biotechnology company developing its first-in-class, anti-infective Aganocide ® compounds for the local non-systemic treatment and prevention of infections, today announced NeutroPhase Skin and Wound Cleanser in combination with negative pressure wound therapy (NPWT) is featured in a case study as a new therapeutic technique for the management of necrotizing fasciitis. The case study titled, "Treatment of Acute Necrotizing Fasciitis Using Adjunctive Pure Hypochlorous Acid," was presented at the 2012 Fall Symposium on Advanced Wound Care (SAWC), in Baltimore, Md.
Necrotizing fasciitis, also known as flesh eating bacteria, is most commonly caused by the group A streptococcus bacteria. The bacteria itself can be cleared with an aggressive course of intravenous antibiotic therapy; however, the toxins secreted by the bacteria are known to destroy soft tissue at the subcutaneous level, causing toxic shock and in some cases death. Because of this, current standard of care for necrotizing fasciitis also involves an aggressive surgical debridement of necrotic tissue, which often leads to multiple amputations."The successful outcome of this particular patient case is exciting because it has lead us to the possible discovery of a new treatment protocol that could preempt the practice of debridement for the treatment of flesh eating bacterial infection," stated, John Crew, MD, FACS, Medical Director, San Francisco Center for Advanced Wound Care at Seton Medical Center, San Francisco, Calif., and co-author of the study. "The new therapeutic technique combines aggressive wound irrigation with a unique pure hypochlorous acid solution known as NeutroPhase and negative pressure wound therapy, which lead to the full recovery of this patient. It is well known that hypochlorous acid has potent in-vitro activity against Strep A bacteria and more importantly has been shown in laboratory studies that it has the ability to neutralize toxins and superantigens produced by the group A streptococcus."
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV